Kyle Malady - 21 May 2021 Form 4 Insider Report for DEXCOM INC (DXCM)

Role
Director
Signature
By: Jereme Sylvain For: Kyle Malady
Issuer symbol
DXCM
Transactions as of
21 May 2021
Transactions value $
$1
Form type
4
Filing time
25 May 2021, 19:56:47 UTC
Previous filing
17 May 2021
Next filing
01 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXCM Common Stock Award $0.91 +910 +71.54% $0.00* 2.18K 21 May 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The RSU Award was granted on May 21, 2021 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2022 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement.
F2 Included in this number are 2,182 unvested restricted stock units, 910 of which were granted on May 21, 2021 and shall vest on the earlier of the one year anniversary of the grant or the date of DexCom Inc's 2022 Annual Meeting and 1,272 of which were granted on October 11, 2020 and shall vest through October 11, 2023.